AGBT | GenomeWeb

AGBT

NanoString said its sequencing technology harnesses its expertise in optical barcodes and that it would develop it for clinical use to complement its existing products.

Researchers described using long-read sequencing technology to develop diagnostic assays, sequence through complex gene fusions, and in virology applications.

Earlier this month at AGBT, company researchers presented the new developments, which Thermo Fisher plans to roll out later this year.

Collaborators will sequence 100,000 Asian genomes from various disease cohorts and generate 50 to 100 Asian-specific reference genomes. 

The Broad Institute is running Chromium in its lab, while other early-access users are collaborating with 10X Genomics on single-cell RNA-seq and exome studies.

Foundation Medicine plans to publish a validation study of its 61-gene liquid biopsy test in a journal and launch the test by the end of the quarter.

The company has scaled back its headcount from a peak of 115 employees to about 100 staff members, primarily on the commercial side.

Illumina's CEO described the one-channel chemistry behind Firefly, saying that its simplicity would allow it to be deployed into new markets, including hospitals.

In early experiments, the method's raw single pass error rate was approximately 2 percent for a single target and up to 4 percent for a mixture of 10 targets. 

The panel is amenable to degraded DNA and mixed samples, which plague both forensics and ancient DNA analysis.

Pages

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.